Function ☕ Monday Insights: Congrats 🎖️ to @edenmgallegos et al., for their #APSselect paper evaluating the effects of ethanol, sugars, and fats on hepatocyte #LipidMetabolism, #OxidativeStress, and #MitochondrialFunction in a spheroid model. Read doi.org/10.1093/func... #MetALD

Discover latest insights and advances in alcohol-associated liver disease, from patient risk and identification to treatment and management, plus the arrival of #MetALD and what it means for patient care.

👉 buff.ly/qjaoBNr

#ALD #MedEd

❗ LAST CHANCE TO REGISTER❗

The global burden of #ALD is growing and compounded by frequent late-stage diagnosis and undertreatment.

Get the latest insights into patient risk and identification, treatment and management, and the arrival of #MetALD.

👉 buff.ly/XbXhwMi

#HepSky #MedSky

With #AASLD2025 coming to a close, continue your learning on #ALD with our upcoming free webinar.

Find out more about advances in treatment and what you need to know about the introduction of #MetALD as a new category of liver disease.

👉 buff.ly/XbXhwMi

#HepSky #MedSky

Keynote webinar | Spotlight on addressing alcohol-associated liver disease

The global burden of #ALD is growing and compounded by frequent late-stage diagnosis and undertreatment.

Get the latest insights into patient risk and identification, treatment and management, and the arrival of #MetALD.

Register now: bit.ly/3Jmukor. #HepSky #MedSky

The global burden of #ALD is growing and compounded by frequent late-stage diagnosis and undertreatment.

Get the latest insights into patient risk and identification, treatment and management, and the arrival of #MetALD.

Register now 👉 buff.ly/zHkugyV

#HepSky #MedSky

The global burden of #ALD is growing and compounded by frequent late-stage diagnosis and undertreatment.

Join our expert-led webinar to gain the latest insights into patient risk and identification, treatment, management, and the arrival of #MetALD.

👉 buff.ly/bF2uOeh

#GastroSky #MedEd

The global burden of #ALD is growing and compounded by frequent late-stage diagnosis and undertreatment.

In this free webinar, get the latest insights into patient risk and identification, treatment and management, and the arrival of #MetALD.

👉 buff.ly/ouN4mFi

#GastroSky #MedEd

If you are a #PCP and wanted to learn more about liver health to benefit your patients (specifically #MASLD #MetALD and #ALD ) what questions would you want answered? What knowledge would help encourage you to screen for MASLD more in primary care?

#LiverSky #AASLD #PrimaryCare

In today’s #readoftheweek📚, discover how targeting DHCR7 can become a strategy for the treatment of #MetALD and #HCC.

Read this JHEP Reports article: www.jhep-reports.eu/article/S258...

@ucsandiego.bsky.social #LiverSky

Cause-specific mortality in patients with steatotic liver disease in the United States Causes of death across steatotic liver disease (SLD) subtypes remain incompletely characterized in routine clinical practice. We aimed to quantify and compare cause-specific mortality in SLD.

🚨Check out our new study in @jhepatology.bsky.social ❗️

Using natural language processing to identify >350,000 patients with #steatosis, we demonstrated that cause-specific mortality differs between #MASLD #MetALD and #ALD

www.journal-of-hepatology.eu/article/S016...

Join us at the Industry Room: Evolving concepts in MASLD, ALD & MetALD at #EASLCongress

Learn about:
✏️ New terminology & pathophysiology
🔬Non-invasive tools for diagnosis, prognosis & monitoring

🚨 Stay updated on the latest in metabolic & alcohol-related liver disease!

#MASLD #MetALD

April issue cover of Nature Reviews Gastroenterology & Hepatology. Image drawn by Neil Smith, Springer Nature Ltd

Our April issue cover 'SLD burden paradox' was inspired by this Perspective that examines the key role of #alcohol in steatotic liver disease

Full link: go.nature.com/4czsiv5
PDF link: rdcu.be/ehGLu

Artist Credit: Neil Smith

#gastrosky #liversky #MASLD #metALD

Metabolic and alcohol-associated liver disease (MetALD): a representation of duality - npj Gut and Liver npj Gut and Liver - Metabolic and alcohol-associated liver disease (MetALD): a representation of duality

So much talk about #MASLD but let's not forget to screen our patients for alcohol consumption as well.

Alcohol + metabolic risk factors synergistically ⬆️steatohepatitis, fibrosis, and hepatocellular carcinoma in #MetALD

nature.com/articles/s44...

Increase in #alcohol use in middle age in all generations
🚨 Worrying trends for Millennials as they reach their 40s+
➕ Rising #obesity
🟰 ⬆️ Liver disease and death
#MetALD

The steatotic liver disease burden paradox: unravelling the key role of alcohol - Nature Reviews Gastroenterology & Hepatology Steatotic liver disease (SLD) encompasses a spectrum of hepatic lipid-accumulation disorders, including metabolic and alcohol-related liver disease. This Perspective introduces the ‘SLD burden paradox...

New in #NatureReviewsGastroHep - this Perspective on the steatotic liver disease burden paradox and the key role of #alcohol
By Nikolaj Torp, Mads Israelsen & Aleksander Krag
www.nature.com/articles/s41...

Free to read: rdcu.be/d2x1o

#MASLD #liversky #metALD

Is there a #hepsky feed? Thanks to all who contributed to the @AASLD2024 #TLM2024 #liversky it was a perfect online experience 🥰 Excellent presentations Learned new treatment options for #MetALD #foodaddiction

@HannesHagstrom presents data suggesting you should just swap existing ICD codes for #NAFLD to #MASLD and #NASH to #MASH and create a new category for #MetALD
People will widely adopt when they can bill appropriately so this is important to address ASAP. @AASLDtweets #TLM23

Fatty Liver= #SLD
#NAFLD= #MASLD
#NASH=#MASH
#MASLD who drink ethanol > 140 g F or 210 g M weekly= #MetALD
Alcohol related liver disease= #ALD
SLD with known cause (drug, Wilson, other genetic etc…) = specific etiology SLD
SLD without known metabolic or other risk= cryptogenic SL